Eastwood Bio-Medical Canada Inc. reported earnings results for the third quarter and nine months ended July 31, 2023. For the third quarter, the company reported sales was CAD 0.171362 million compared to CAD 0.268605 million a year ago. Revenue was CAD 0.187017 million compared to CAD 0.285228 million a year ago. Net loss was CAD 0.117301 million compared to CAD 0.085313 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago.
For the nine months, sales was CAD 0.649528 million compared to CAD 0.818124 million a year ago. Revenue was CAD 0.738854 million compared to CAD 0.918852 million a year ago. Net loss was CAD 0.362365 million compared to CAD 0.124916 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago.